# IDEAYA Biosciences, Inc.: filings

IDYA · Nasdaq · CIK 1676725 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/idya.md) · [Financials](/companies/idya/financials.md) · [Filings](/companies/idya/filings.md) · [Insiders](/companies/idya/insiders.md)

## Reports and events: 150 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 167, 8-K 104, SC 13G/A 29, 3 28, 10-Q 22, 144 21, SC 13G 21, 424B5 19, S-8 10, SCHEDULE 13G/A 8, 10-K 7, DEF 14A 7, CORRESP 5, UPLOAD 5, ARS 4, SCHEDULE 13G 4, DRS/A 3, DRSLTR 3, EFFECT 3, S-1/A 3, SC 13D/A 3, 3/A 2, D 2, S-3 2, S-3ASR 2, SEC STAFF LETTER 2, 10-Q/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, CT ORDER 1, DEFA14A 1, DRS 1, S-1 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 20:05 ET | [10-Q](/filings/0001193125-26-332774.md) | Quarterly report, period 2026-06-30 | 0001193125-26-332774 |
| 2026-08-04 | 10:01 ET | [8-K](/filings/0001193125-26-331381.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331381 |
| 2026-06-23 | 20:05 ET | [8-K](/filings/0001193125-26-279427.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-279427 |
| 2026-06-10 | 20:10 ET | [8-K](/filings/0001193125-26-265833.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-265833 |
| 2026-06-03 | 10:01 ET | [8-K](/filings/0001193125-26-254476.md) | 8.01 Other events | 0001193125-26-254476 |
| 2026-06-01 | 20:05 ET | [8-K](/filings/0001193125-26-251399.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-251399 |
| 2026-05-05 | 21:21 ET | [8-K](/filings/0001193125-26-206806.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-206806 |
| 2026-05-05 | 20:05 ET | [10-Q](/filings/0001193125-26-206357.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206357 |
| 2026-05-05 | 10:05 ET | [8-K](/filings/0001193125-26-204944.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204944 |
| 2026-04-29 | 20:05 ET | [DEF 14A](/filings/0001193125-26-191501.md) | Proxy statement, period 2026-06-16 | 0001193125-26-191501 |
| 2026-04-13 | 10:05 ET | [8-K](/filings/0001193125-26-151893.md) | 8.01 Other events | 0001193125-26-151893 |
| 2026-04-09 | 10:01 ET | [8-K](/filings/0001193125-26-148777.md) | 8.01 Other events | 0001193125-26-148777 |
| 2026-02-17 | 21:00 ET | [10-K](/filings/0001193125-26-054533.md) | Annual report, period 2025-12-31 | 0001193125-26-054533 |
| 2026-02-17 | 11:04 ET | [8-K](/filings/0001193125-26-052741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-052741 |
| 2026-01-12 | 11:11 ET | [8-K](/filings/0001193125-26-009653.md) | 8.01 Other events | 0001193125-26-009653 |
| 2026-01-12 | 11:05 ET | [8-K](/filings/0001193125-26-009641.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009641 |
| 2025-12-12 | 21:05 ET | [8-K](/filings/0001193125-25-317541.md) | 1.02 Termination of a material agreement | 0001193125-25-317541 |
| 2025-12-05 | 21:19 ET | [8-K](/filings/0001193125-25-309716.md) | 8.01 Other events | 0001193125-25-309716 |
| 2025-11-04 | 21:04 ET | [10-Q](/filings/0001193125-25-264632.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264632 |
| 2025-11-04 | 11:02 ET | [8-K](/filings/0001193125-25-263383.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263383 |
| 2025-10-20 | 20:05 ET | [8-K](/filings/0001193125-25-243558.md) | 8.01 Other events | 0001193125-25-243558 |
| 2025-09-08 | 10:08 ET | [8-K](/filings/0001193125-25-197605.md) | 8.01 Other events | 0001193125-25-197605 |
| 2025-09-02 | 10:02 ET | [8-K](/filings/0001193125-25-193238.md) | 1.01 Entry into a material agreement | 0001193125-25-193238 |
| 2025-08-05 | 20:01 ET | [10-Q](/filings/0000950170-25-102967.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102967 |
| 2025-08-05 | 10:04 ET | [8-K](/filings/0000950170-25-102353.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102353 |
| 2025-06-27 | 20:06 ET | [8-K](/filings/0001193125-25-151257.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-151257 |
| 2025-06-24 | 21:27 ET | [8-K](/filings/0001193125-25-145830.md) | 5.07 Shareholder vote results | 0001193125-25-145830 |
| 2025-05-06 | 20:05 ET | [10-Q](/filings/0000950170-25-064438.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064438 |
| 2025-05-06 | 10:05 ET | [8-K](/filings/0000950170-25-063938.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063938 |
| 2025-04-30 | 10:06 ET | [DEF 14A](/filings/0000950170-25-060530.md) | Proxy statement, period 2025-06-24 | 0000950170-25-060530 |
| 2025-04-02 | 20:01 ET | [8-K](/filings/0001193125-25-071309.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-071309 |
| 2025-02-18 | 21:00 ET | [10-K](/filings/0000950170-25-022183.md) | Annual report, period 2024-12-31 | 0000950170-25-022183 |
| 2025-02-13 | 11:05 ET | [8-K](/filings/0000950170-25-019314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-019314 |
| 2025-02-10 | 11:05 ET | [8-K](/filings/0001193125-25-023076.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-023076 |
| 2024-12-30 | 11:04 ET | [8-K](/filings/0001193125-24-286169.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-286169 |
| 2024-11-04 | 21:05 ET | [10-Q](/filings/0000950170-24-120675.md) | Quarterly report, period 2024-09-30 | 0000950170-24-120675 |
| 2024-11-04 | 11:03 ET | [8-K](/filings/0000950170-24-120257.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-120257 |
| 2024-10-25 | 10:04 ET | [8-K](/filings/0001193125-24-243413.md) | 8.01 Other events | 0001193125-24-243413 |
| 2024-10-04 | 20:01 ET | [8-K](/filings/0001193125-24-233038.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-233038 |
| 2024-09-23 | 10:12 ET | [8-K](/filings/0001193125-24-223230.md) | 8.01 Other events | 0001193125-24-223230 |
| 2024-08-06 | 20:13 ET | [10-Q](/filings/0000950170-24-091823.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091823 |
| 2024-08-06 | 20:01 ET | [10-Q/A](/filings/0001193125-24-194852.md) | Quarterly report, amended, period 2024-03-31 | 0001193125-24-194852 |
| 2024-08-06 | 10:04 ET | [8-K](/filings/0000950170-24-091175.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091175 |
| 2024-07-31 | 10:03 ET | [8-K](/filings/0000950170-24-088200.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-088200 |
| 2024-07-11 | 20:12 ET | [8-K](/filings/0001193125-24-177726.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-177726 |
| 2024-07-09 | 20:11 ET | [8-K](/filings/0001193125-24-176736.md) | 2.02 Results of operations; 8.01 Other events | 0001193125-24-176736 |
| 2024-07-08 | 10:04 ET | [8-K](/filings/0001193125-24-175867.md) | 8.01 Other events | 0001193125-24-175867 |
| 2024-06-27 | 10:06 ET | [8-K](/filings/0001193125-24-169573.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-169573 |
| 2024-06-03 | 10:05 ET | [8-K](/filings/0000950170-24-067644.md) | 8.01 Other events | 0000950170-24-067644 |
| 2024-05-31 | 20:54 ET | [8-K](/filings/0000950170-24-067407.md) | 5.07 Shareholder vote results | 0000950170-24-067407 |

Page 1 of 3. [Older](/companies/idya/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.